Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 20,610 |
|
|||||
| News | - | ||||||
| Day High | 1.87 | Low High |
|||||
| Day Low | 1.77 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| 180 Life Sciences Corporation | ATNF | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.0512 | 2.89% | 1.82 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.81 | 1.77 | 1.87 | 1.80 | 1.7688 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 242 | 20,610 | US$ 1.83 | US$ 37,739 | - | 1.33 - 27.93 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:39:59 | 1 | US$ 1.77 | USD |
180 Life Sciences Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.07M | 593.20k | - | 0 | -19.94M | -33.61 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
180 Life Sciences News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/14/2024 | 07:30 | GlobeNewswire Inc. | 180 Life Sciences Regains Full Compliance with Nasdaq .. |
| 3/11/2024 | 06:03 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/08/2024 | 15:49 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/29/2024 | 07:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/28/2024 | 05:42 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 2/28/2024 | 05:39 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 2/28/2024 | 05:37 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 2/28/2024 | 05:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/26/2024 | 06:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/26/2024 | 06:00 | GlobeNewswire Inc. | 180 Life Sciences Corp. Announces 1-For 19 Reverse Stock.. |
| 2/20/2024 | 07:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/16/2024 | 16:10 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ATNF Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.80 | 2.07 | 1.68 | 1.84 | 26,178 | 0.02 | 1.11% |
| 1 Month | 2.24 | 2.60 | 1.33 | 1.86 | 78,438 | -0.42 | -18.75% |
| 3 Months | 3.781 | 4.75 | 1.33 | 3.38 | 209,851 | -1.96 | -51.86% |
| 6 Months | 8.17 | 9.234 | 1.33 | 4.57 | 698,439 | -6.35 | -77.72% |
| 1 Year | 20.33 | 27.93 | 1.33 | 9.41 | 524,766 | -18.51 | -91.05% |
| 3 Years | 182.40 | 223.25 | 1.33 | 60.87 | 804,091 | -180.58 | -99.00% |
| 5 Years | 197.22 | 247.8607 | 1.33 | 80.73 | 805,316 | -195.40 | -99.08% |
180 Life Sciences Description
| 180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics. |
